FOS Capital, through its Aldridge Traffic Systems arm, has landed its largest contract to date, supplying advanced ITS lighting for a major Victorian freeway upgrade, lifting its order book to $9 million.
TruScreen has been confirmed as a superior primary cervical cancer screening device in the world’s largest opto-electronic study, outperforming traditional cytology and matching HPV testing accuracy.